Dysentery polyvalent bacteriophage
Bacteriophages
Description
The preparation causes specific lysis of pathogens of bacterial dysentery.
Presentation
Solution for oral and rectal administration in 20 ml or 100 ml vials. Four or ten 20 ml vials or one 100 ml vial in each cardboard package with a package insert.
Ingredients
The preparation is a mixture of sterile filtrates of phage lysates of Shigellaflexneri of 1, 2, 3, 4, 6 serovariants and Shigellasonnei.
Excipients:
- preservative - 8-hydroxyquinoline sulfate monohydrate - 0.0001 g/ml (estimated content);
- or 8-hydroxyquinoline sulfate monohydrate - 0.0001 g/ml (equal to 8-hydroxyquinoline sulfate, estimated content).
Indications
Treatment and prevention of bacterial dysentery caused by Shigellaflexneri of 1, 2, 3, 4, 6 serovariants and Shigellasonnei.
An important condition for the effective phage therapy is a preliminary determination of the phage sensitivity of the pathogen.
